Skip to main content
Search Open Menu Close Menu
Back to Events

Foundation Medicine Live at the 2022 ASCO Annual Meeting

Find Answers. Take Action.

Your Essential Partner in Cancer Care.

Visit us at Booth 13019 at this year’s American Society of Clinical Oncology (ASCO) Annual Meeting to learn more about how we’re delivering comprehensive genomic insights to help providers and researchers find answers and take action on innovative treatment options for patients with cancer.

Our team will be on-site to discuss:

  • How our proven portfolio of tests, including FoundationOne Liquid CDx, the broadest FDA-approved liquid biopsy, can help guide treatment strategies for patients with advanced cancer.

  • Our commitment to simplifying report interpretation, including recent enhancements we’ve made to our test reports to increase visibility to all actionable findings 

  • Our integrations with leading EMRs, designed to improve workflow efficiency and help simplify the clinical decision-making process

June 3 - 7, 2022

McCormick Place,
2301 S King Dr, Chicago, IL 60616

Visit ASCO Website

Featured Event and Poster Discussion

Foundation Medicine's ASCO Reception

SUNDAY, JUNE 5 | 7:00 PM - 10:00 PM CDT

We hope you will join us to celebrate the close of another great conference, to speak with the authors of the compelling data we will be presenting, and to learn more from our patient and physician speakers about the impact of Foundation Medicine comprehensive genomic profiling.
Register

Poster Discussion

SUNDAY JUNE 5 | 8:00 AM – 11:00 AM CDT

TITLE: Genomic landscape of acquired resistance to targeted therapies in patients with solid tumors: a study from the National Center for Precision Medicine (PRISM)
ABSTRACT: 3016
TRACK: Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Posters & Presentations

  • Poster Session

    Genomic Profile of Intrahepatic Cholangiocarcinoma with MTAP loss

    Session Title

    Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

    Abstract/Poster Number

    4102/89

    Time

    8:00 AM-11:00 AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    The Landscape of Homologous Recombination Reversion Mutations in Pancreatobiliary Malignancies

    Session Title

    Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

    Abstract/Poster Number

    4156/141

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Molecular Characteristics of Advanced Colorectal Cancer and Multi-hit PIK3CA Mutations

    Session Title

    Gastrointestinal Cancer—Colorectal and Anal

    Abstract/Poster Number

    3535/329

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Comprehensive Genomic Profiling (CGP) of Chromophobe Renal Cell Carcinoma (chrRCC) Compared with Non-Chromophobe RCC (nonchrRCC): Impact of FLCN Genomic Alteration (GA) Status

    Session Title

    Genitourinary Cancer—Kidney and Bladder

    Abstract/Poster Number

    4550/41

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Landscape of Fibroblast Growth Factor Receptor (FGFR) Genomic Alterations (GA) in Urothelial Bladder Cancer (UBC)

    Session Title

    Genitourinary Cancer—Kidney and Bladder

    Abstract/Poster Number

    4568/59

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Biomarker Associations of Immune Checkpoint Inhibitor Versus Chemotherapy Effectiveness in First-Line Metastatic Endometrial Carcinomas: A Real-World Study

    Session Title

    Gynecologic Cancer

    Abstract/Poster Number

    5596/472

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    The Landscape of Homologous Recombination Reversion Mutations in Gynecologic Malignancies

    Session Title

    Gynecologic Cancer

    Abstract/Poster Number

    5576/452

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Pan-Cancer Landscape of CD274 (PD-L1) and PDCD1LG2 (PD-L2) Structural Variations

    Session Title

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Abstract/Poster Number

    3133/125

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Insights of Clinical Significance from Solid Tumor Profiles With FoundationOne®CDx

    Session Title

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Abstract/Poster Number

    3126/118

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Discussion

    Genomic Landscape of Acquired Resistance to Targeted Therapies in Patients with Solid Tumors: A Study from The National Center for Precision Medicine (PRISM)

    Session Title

    Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

    Abstract/Poster Number

    3016/8

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Genomic Characterization of Thymic Epithelial Tumor from Real-World Data

    Session Title

    Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

    Abstract/Poster Number

    8587/213

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Ancestry-Based Differences in Gene Alterations in Non-Small Cell Lung Cancer: Real-World Data Using Genetic Ancestry Analysis

    Session Title

    Lung Cancer—Non-Small Cell Metastatic

    Abstract/Poster Number

    9125/111

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Real World Analysis of Quantitative MET Copy Number (CN) As A Biomarker in Advanced NSCLC (aNSCLC)

    Session Title

    Lung Cancer—Non-Small Cell Metastatic

    Abstract/Poster Number

    9123/109

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    A Real-World (RW) Evidence Study Quantifying The Clinical Value of Multi-Gene Testing in Early-Stage Lung Adenocarcinoma (LUAD)

    Session Title

    Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

    Abstract/Poster Number

    8525/152

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    ctDNA Shed and Outcomes for Patients (pts) with Advanced Non-small Cell Lung Cancer (aNSCLC) Treated with Immune Checkpoint Inhibitors (ICPI)

    Session Title

    Lung Cancer—Non-Small Cell Metastatic

    Abstract/Poster Number

    9045/33

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Clinical and Genomic Characteristics of PTS with Durable Benefit from Immune Checkpoint Inhibitors (ICI) in Advanced (aNSCLC)

    Session Title

    Lung Cancer—Non-Small Cell Metastatic

    Abstract/Poster Number

    9048/36

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Activating MET Kinase Domain Mutations Define A Novel Molecular Subtype of Non-Small Cell Lung Cancer That Is Clinically Targetable with The MET Inhibitor Elzovantinib (TPX-0022)

    Session Title

    Lung Cancer—Non-Small Cell Metastatic

    Abstract/Poster Number

    9124/110

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    LCMC LEADER Neoadjuvant Screening Trial: LCMC4 Evaluation of Actionable Drivers in Early Stage Lung Cancers

    Session Title

    Lung Cancer - Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers

    Abstract/Poster Number

    TPS8596/219a

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    The Mutational Profile of ER-PR+HER2- Metastatic Breast Cancer

    Session Title

    Breast Cancer— Metastatic

    Abstract/Poster Number

    1025/403

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Targetable Genomic Mutations in Young Women with Advanced Breast Cancer

    Session Title

    Breast Cancer—Metastatic

    Abstract/Poster Number

    1027/405

    Time

    8:00AM–11:00AM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Association of RB1 Mutational Status with Overall Genomic Landscape in Neuroendocrine Prostate Cancer (NEPC)

    Session Title

    Genitourinary Cancer—Prostate

    Abstract/Poster Number

    5063/246

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster

  • Poster Session

    Distinct Mutational Landscapes Characterize Melanomas Metastatic to Different Anatomical Sites

    Session Title

    Melanoma/Skin Cancers

    Abstract/Poster Number

    9562/155

    Time

    1:15PM–4:15PM CDT

    Location

    Hall A

    View Abstract & Poster